OR WAIT null SECS
August 01, 2019
Mass-produce cell and gene therapies presents the biopharma industry with a unique set of challenges.
Researchers in China are playing a role in advancing gene therapy development.
July 29, 2019
Iontas and Teva Pharmaceuticals have entered into an agreement for the application of technologies and know-how into the optimization of human antibodies to be used as biotherapeutics.
July 02, 2019
The increasing growth in the cell- and gene-therapy markets is inspiring CDMOs to expand their services in this emerging biologic drug arena.
FDA and USP take sides in debate on biologic drug standards.
July 01, 2019
Novavax will sell two Maryland-based vaccine development and manufacturing facilities for Catalent’s expanding gene therapy footprint.
June 25, 2019
The US Senate and the US Pharmacopeial Convention debate the necessity of monographs for biologics.
June 24, 2019
The biosimilar, Kanjinti, is approved for all indications of Herceptin, which includes treating breast, gastric, and gastroesophogeal cancers.
June 18, 2019
Centre for Process Innovation (CPI) is set to host an event in Darlington, UK, on June 26, 2019 to showcase the results of a £11.2-million (US$14.03-million) collaborative project to optimize biotherapeutic development.
June 07, 2019
The acquisition will boost Biogen’s gene-therapy pipeline with the addition of two mid- to late-stage clinical assets and preclinical programs.